Selected research
Market Analysis & Forecast
Global Calming and Sleeping Market Analysis and Forecast 2026-2032
Market perspective
The global Calming and Sleeping market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Calming and Sleeping is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Calming and Sleeping is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Calming and Sleeping is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Calming and Sleeping is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Calming and Sleeping include Teva Pharmaceutical, Johnson & Johnson, Eli Lilly, AstraZeneca, Sunovion Pharmaceuticals, Roscoe Medical, Durect, Collegium Pharmaceutical and Cara Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Calming and Sleeping, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Calming and Sleeping, also provides the sales of main regions and countries. Of the upcoming market potential for Calming and Sleeping, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Calming and Sleeping sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Calming and Sleeping market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Calming and Sleeping sales, projected growth trends, production technology, application and end-user industry.
Calming and Sleeping Segment by Company
Teva Pharmaceutical
Johnson & Johnson
Eli Lilly
AstraZeneca
Sunovion Pharmaceuticals
Roscoe Medical
Durect
Collegium Pharmaceutical
Cara Therapeutics
Acura Pharmaceuticals
Calming and Sleeping Segment by Type
Medications
Sleep Laboratories
Sleep Apnea Devices
Mattresses and Pillows
Prescriptions
Over-The-Counter (OTC)
Calming and Sleeping Segment by Application
Restless Leg Syndrome (RLS)
Narcolepsy
Sleepwalking
Bruxism
Insomnia
Sleep apnea
Calming and Sleeping Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming and Sleeping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Calming and Sleeping and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming and Sleeping.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Calming and Sleeping in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Calming and Sleeping manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Calming and Sleeping sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medications
- Sleep Laboratories
- Sleep Apnea Devices
- Mattresses and Pillows
- Prescriptions
- Over-The-Counter (OTC)
Applications
- Restless Leg Syndrome (RLS)
- Narcolepsy
- Sleepwalking
- Bruxism
- Insomnia
- Sleep apnea
Companies covered
- Teva Pharmaceutical
- Johnson & Johnson
- Eli Lilly
- AstraZeneca
- Sunovion Pharmaceuticals
- Roscoe Medical
- Durect
- Collegium Pharmaceutical
- Cara Therapeutics
- Acura Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Calming and Sleeping Market by Type
- 1.2.1 Global Calming and Sleeping Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Medications
- 1.2.3 Sleep Laboratories
- 1.2.4 Sleep Apnea Devices
- 1.2.5 Mattresses and Pillows
- 1.2.6 Prescriptions
- 1.2.7 Over-The-Counter (OTC)
- 1.3 Calming and Sleeping Market by Application
- 1.3.1 Global Calming and Sleeping Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Restless Leg Syndrome (RLS)
- 1.3.3 Narcolepsy
- 1.3.4 Sleepwalking
- 1.3.5 Bruxism
- 1.3.6 Insomnia
- 1.3.7 Sleep apnea
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Calming and Sleeping Market Dynamics
- 2.1 Calming and Sleeping Industry Trends
- 2.2 Calming and Sleeping Industry Drivers
- 2.3 Calming and Sleeping Industry Opportunities and Challenges
- 2.4 Calming and Sleeping Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Calming and Sleeping Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Calming and Sleeping Revenue by Region
- 3.2.1 Global Calming and Sleeping Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Calming and Sleeping Revenue by Region (2021-2026)
- 3.2.3 Global Calming and Sleeping Revenue by Region (2027-2032)
- 3.2.4 Global Calming and Sleeping Revenue Market Share by Region (2021-2032)
- 3.3 Global Calming and Sleeping Sales Estimates and Forecasts 2021-2032
- 3.4 Global Calming and Sleeping Sales by Region
- 3.4.1 Global Calming and Sleeping Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Calming and Sleeping Sales by Region (2021-2026)
- 3.4.3 Global Calming and Sleeping Sales by Region (2027-2032)
- 3.4.4 Global Calming and Sleeping Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Calming and Sleeping Revenue by Manufacturers
- 4.1.1 Global Calming and Sleeping Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Calming and Sleeping Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Calming and Sleeping Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Calming and Sleeping Sales by Manufacturers
- 4.2.1 Global Calming and Sleeping Sales by Manufacturers (2021-2026)
- 4.2.2 Global Calming and Sleeping Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Calming and Sleeping Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Calming and Sleeping Sales Price by Manufacturers (2021-2026)
- 4.4 Global Calming and Sleeping Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Calming and Sleeping Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Calming and Sleeping Manufacturers, Product Type & Application
- 4.7 Global Calming and Sleeping Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Calming and Sleeping Market CR5 and HHI
- 4.8.2 2025 Calming and Sleeping Tier 1, Tier 2, and Tier 3
5 Calming and Sleeping Market by Type
- 5.1 Global Calming and Sleeping Revenue by Type
- 5.1.1 Global Calming and Sleeping Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Calming and Sleeping Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Calming and Sleeping Revenue Market Share by Type (2021-2032)
- 5.2 Global Calming and Sleeping Sales by Type
- 5.2.1 Global Calming and Sleeping Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Calming and Sleeping Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Calming and Sleeping Sales Market Share by Type (2021-2032)
- 5.3 Global Calming and Sleeping Price by Type
6 Calming and Sleeping Market by Application
- 6.1 Global Calming and Sleeping Revenue by Application
- 6.1.1 Global Calming and Sleeping Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Calming and Sleeping Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Calming and Sleeping Revenue Market Share by Application (2021-2032)
- 6.2 Global Calming and Sleeping Sales by Application
- 6.2.1 Global Calming and Sleeping Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Calming and Sleeping Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Calming and Sleeping Sales Market Share by Application (2021-2032)
- 6.3 Global Calming and Sleeping Price by Application
7 Company Profiles
- 7.1 Teva Pharmaceutical
- 7.1.1 Teva Pharmaceutical Company Information
- 7.1.2 Teva Pharmaceutical Business Overview
- 7.1.3 Teva Pharmaceutical Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Teva Pharmaceutical Calming and Sleeping Product Portfolio
- 7.1.5 Teva Pharmaceutical Recent Developments
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Company Information
- 7.2.2 Johnson & Johnson Business Overview
- 7.2.3 Johnson & Johnson Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Johnson & Johnson Calming and Sleeping Product Portfolio
- 7.2.5 Johnson & Johnson Recent Developments
- 7.3 Eli Lilly
- 7.3.1 Eli Lilly Company Information
- 7.3.2 Eli Lilly Business Overview
- 7.3.3 Eli Lilly Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Eli Lilly Calming and Sleeping Product Portfolio
- 7.3.5 Eli Lilly Recent Developments
- 7.4 AstraZeneca
- 7.4.1 AstraZeneca Company Information
- 7.4.2 AstraZeneca Business Overview
- 7.4.3 AstraZeneca Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 AstraZeneca Calming and Sleeping Product Portfolio
- 7.4.5 AstraZeneca Recent Developments
- 7.5 Sunovion Pharmaceuticals
- 7.5.1 Sunovion Pharmaceuticals Company Information
- 7.5.2 Sunovion Pharmaceuticals Business Overview
- 7.5.3 Sunovion Pharmaceuticals Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Sunovion Pharmaceuticals Calming and Sleeping Product Portfolio
- 7.5.5 Sunovion Pharmaceuticals Recent Developments
- 7.6 Roscoe Medical
- 7.6.1 Roscoe Medical Company Information
- 7.6.2 Roscoe Medical Business Overview
- 7.6.3 Roscoe Medical Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Roscoe Medical Calming and Sleeping Product Portfolio
- 7.6.5 Roscoe Medical Recent Developments
- 7.7 Durect
- 7.7.1 Durect Company Information
- 7.7.2 Durect Business Overview
- 7.7.3 Durect Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Durect Calming and Sleeping Product Portfolio
- 7.7.5 Durect Recent Developments
- 7.8 Collegium Pharmaceutical
- 7.8.1 Collegium Pharmaceutical Company Information
- 7.8.2 Collegium Pharmaceutical Business Overview
- 7.8.3 Collegium Pharmaceutical Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Collegium Pharmaceutical Calming and Sleeping Product Portfolio
- 7.8.5 Collegium Pharmaceutical Recent Developments
- 7.9 Cara Therapeutics
- 7.9.1 Cara Therapeutics Company Information
- 7.9.2 Cara Therapeutics Business Overview
- 7.9.3 Cara Therapeutics Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Cara Therapeutics Calming and Sleeping Product Portfolio
- 7.9.5 Cara Therapeutics Recent Developments
- 7.10 Acura Pharmaceuticals
- 7.10.1 Acura Pharmaceuticals Company Information
- 7.10.2 Acura Pharmaceuticals Business Overview
- 7.10.3 Acura Pharmaceuticals Calming and Sleeping Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Acura Pharmaceuticals Calming and Sleeping Product Portfolio
- 7.10.5 Acura Pharmaceuticals Recent Developments
8 North America
- 8.1 North America Calming and Sleeping Market Size by Type
- 8.1.1 North America Calming and Sleeping Revenue by Type (2021-2032)
- 8.1.2 North America Calming and Sleeping Sales by Type (2021-2032)
- 8.1.3 North America Calming and Sleeping Price by Type (2021-2032)
- 8.2 North America Calming and Sleeping Market Size by Application
- 8.2.1 North America Calming and Sleeping Revenue by Application (2021-2032)
- 8.2.2 North America Calming and Sleeping Sales by Application (2021-2032)
- 8.2.3 North America Calming and Sleeping Price by Application (2021-2032)
- 8.3 North America Calming and Sleeping Market Size by Country
- 8.3.1 North America Calming and Sleeping Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Calming and Sleeping Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Calming and Sleeping Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Calming and Sleeping Market Size by Type
- 9.1.1 Europe Calming and Sleeping Revenue by Type (2021-2032)
- 9.1.2 Europe Calming and Sleeping Sales by Type (2021-2032)
- 9.1.3 Europe Calming and Sleeping Price by Type (2021-2032)
- 9.2 Europe Calming and Sleeping Market Size by Application
- 9.2.1 Europe Calming and Sleeping Revenue by Application (2021-2032)
- 9.2.2 Europe Calming and Sleeping Sales by Application (2021-2032)
- 9.2.3 Europe Calming and Sleeping Price by Application (2021-2032)
- 9.3 Europe Calming and Sleeping Market Size by Country
- 9.3.1 Europe Calming and Sleeping Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Calming and Sleeping Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Calming and Sleeping Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
10 China
- 10.1 China Calming and Sleeping Market Size by Type
- 10.1.1 China Calming and Sleeping Revenue by Type (2021-2032)
- 10.1.2 China Calming and Sleeping Sales by Type (2021-2032)
- 10.1.3 China Calming and Sleeping Price by Type (2021-2032)
- 10.2 China Calming and Sleeping Market Size by Application
- 10.2.1 China Calming and Sleeping Revenue by Application (2021-2032)
- 10.2.2 China Calming and Sleeping Sales by Application (2021-2032)
- 10.2.3 China Calming and Sleeping Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Calming and Sleeping Market Size by Type
- 11.1.1 Asia Calming and Sleeping Revenue by Type (2021-2032)
- 11.1.2 Asia Calming and Sleeping Sales by Type (2021-2032)
- 11.1.3 Asia Calming and Sleeping Price by Type (2021-2032)
- 11.2 Asia Calming and Sleeping Market Size by Application
- 11.2.1 Asia Calming and Sleeping Revenue by Application (2021-2032)
- 11.2.2 Asia Calming and Sleeping Sales by Application (2021-2032)
- 11.2.3 Asia Calming and Sleeping Price by Application (2021-2032)
- 11.3 Asia Calming and Sleeping Market Size by Country
- 11.3.1 Asia Calming and Sleeping Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Calming and Sleeping Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Calming and Sleeping Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Calming and Sleeping Market Size by Type
- 12.1.1 SAMEA Calming and Sleeping Revenue by Type (2021-2032)
- 12.1.2 SAMEA Calming and Sleeping Sales by Type (2021-2032)
- 12.1.3 SAMEA Calming and Sleeping Price by Type (2021-2032)
- 12.2 SAMEA Calming and Sleeping Market Size by Application
- 12.2.1 SAMEA Calming and Sleeping Revenue by Application (2021-2032)
- 12.2.2 SAMEA Calming and Sleeping Sales by Application (2021-2032)
- 12.2.3 SAMEA Calming and Sleeping Price by Application (2021-2032)
- 12.3 SAMEA Calming and Sleeping Market Size by Country
- 12.3.1 SAMEA Calming and Sleeping Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Calming and Sleeping Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Calming and Sleeping Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Calming and Sleeping Value Chain Analysis
- 13.1.1 Calming and Sleeping Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Calming and Sleeping Production Mode & Process
- 13.2 Calming and Sleeping Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Calming and Sleeping Distributors
- 13.2.3 Calming and Sleeping Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst